Medha Rajappa1, Devinder Mohan Thappa2, Laxmisha Chandrashekar2, Malathi Munisamy2, G Revathy1. 1. Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India. 2. Department of Dermatology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Abstract
OBJECTIVES: Psoriasis is a chronic inflammatory skin disease. Chronic inflammation results in increased oxidative stress and oxidizes lipoproteins, increasing their atherogenicity. This study sought to estimate the levels of oxidized low-density lipoprotein (ox-LDL) and antibodies against oxidized LDL (anti-ox-LDL) and compute the ratio of anti-ox-LDL/ox-LDL as a single composite parameter to assess the oxidative lipoprotein burden as an indicator of cardiovascular risk in patients with psoriasis. METHODS: This cross-sectional study included 45 patients with psoriasis. All patients were given a psoriasis severity index score and their ox-LDL and anti-ox-LDL estimated using ELISA. RESULTS: The results of this study show an elevation in the ratio of anti-ox-LDL to ox-LDL in patients with psoriasis, which initiate and perpetuate the pathogenesis of psoriasis and its comorbidity, atherosclerotic cardiovascular disease. CONCLUSIONS: Our results suggest that an elevated ratio of anti-ox-LDL/ox-LDL can serve as a composite parameter reflecting the total oxidative lipoprotein burden and cardiovascular risk in psoriasis patients.
OBJECTIVES:Psoriasis is a chronic inflammatory skin disease. Chronic inflammation results in increased oxidative stress and oxidizes lipoproteins, increasing their atherogenicity. This study sought to estimate the levels of oxidized low-density lipoprotein (ox-LDL) and antibodies against oxidized LDL (anti-ox-LDL) and compute the ratio of anti-ox-LDL/ox-LDL as a single composite parameter to assess the oxidative lipoprotein burden as an indicator of cardiovascular risk in patients with psoriasis. METHODS: This cross-sectional study included 45 patients with psoriasis. All patients were given a psoriasis severity index score and their ox-LDL and anti-ox-LDL estimated using ELISA. RESULTS: The results of this study show an elevation in the ratio of anti-ox-LDL to ox-LDL in patients with psoriasis, which initiate and perpetuate the pathogenesis of psoriasis and its comorbidity, atherosclerotic cardiovascular disease. CONCLUSIONS: Our results suggest that an elevated ratio of anti-ox-LDL/ox-LDL can serve as a composite parameter reflecting the total oxidative lipoprotein burden and cardiovascular risk in psoriasispatients.
Entities:
Keywords:
Cardiovascular Disease; Oxidative Stress; Oxidized Low Density Lipoprotein; Psoriasis
Authors: Jan Nilsson; Gunilla Nordin Fredrikson; Alexandru Schiopu; Prediman K Shah; Bo Jansson; Roland Carlsson Journal: Curr Pharm Des Date: 2007 Impact factor: 3.116
Authors: Aldona Pietrzak; Paweł Chabros; Ewelina Grywalska; Paweł Kiciński; Kinga Pietrzak-Franciszkiewicz; Dorota Krasowska; Grzegorz Kandzierski Journal: Arch Med Sci Date: 2018-03-08 Impact factor: 3.318